Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes
Clinical trial NCT03579160 · TERMINATED
Trial details
- NCT number
- NCT03579160
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2022-01-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.